Agency Forms Undergoing Paperwork Reduction Act Review, 33352-33353 [2024-09145]
Download as PDF
<![CDATA[
33352
Federal Register / Vol. 89, No. 83 / Monday, April 29, 2024 / Notices
b Based on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
c Based on an average of the mean wages for 29–1069 Physicians and Surgeons, All Other and 29–9099 Miscellaneous Health Practitioners
and Technical Workers: Healthcare Practitioners and Technical Workers, All Other.
Request for Comments
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: April 23, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024–09071 Filed 4–26–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-24–1074]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Colorectal
Cancer Control Program (CRCCP)
Monitoring Activities’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on December
22, 2023 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
VerDate Sep<11>2014
20:54 Apr 26, 2024
Jkt 262001
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Colorectal Cancer Control Program
(CRCCP) Monitoring Activities (OMB
Control No. 0920–1074)—
Reinstatement—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Background and Brief Description
CDC is requesting a Reinstatement of
OMB No. 0920–1074. Colorectal cancer
(CRC) is the second leading cause of
death from cancer in the United States
among cancers that affect both men and
women. There is substantial evidence
that CRC screening reduces the
incidence of and death from the disease.
Screening for CRC can detect disease
early when treatment is more effective,
and prevent cancer by finding and
removing precancerous polyps. Of
individuals diagnosed with early stage
CRC, more than 90% live five or more
years. To reduce CRC morbidity,
mortality, and associated costs, use of
CRC screening tests must be increased
among age-eligible adults with the
lowest CRC screening rates.
The purpose of the Colorectal Cancer
Control Program (CRCCP) is to partner
with health systems and their
individual primary care clinics to
implement evidence-based
interventions (EBIs) to increase CRC
screening among defined populations of
adults ages 50–75 that have CRC
screening rates lower than the national,
regional, or local rate. In 2020, CDC
issued the funding opportunity, Public
Health and Health System Partnerships
to Increase Colorectal Cancer Screening
in Clinical Settings (DP20–2002), a fiveyear cooperative agreement to increase
CRC screening among defined
populations of adults ages 50–75 that
have CRC screening rates lower than the
national, regional, or local rate. DP20–
2002 funds recipients to partner with
health systems and their primary care
clinics to implement multiple EBIs,
partner with organizations to support
implementation of EBIs in those clinics,
and collect high-quality clinic-level data
to monitor EBI implementation and
assess screening rate changes.
CDC proposes information collection
using three data collection tools: the
Annual Awardee Survey, Clinic-Level
Data Collection Instrument, and
Quarterly Program Update.
The Annual Awardee Survey is
administered once per year and
assesses: program management, clinic
readiness assessment activities, data
management, technical assistance (TA)
needs, partnerships, and the effect of
COVID–19 on CRC implementation. The
Clinic-Level Information Collection
Instrument is administered three
months following each program year
end and assesses: health system and
E:\FR\FM\29APN1.SGM
29APN1
33353
Federal Register / Vol. 89, No. 83 / Monday, April 29, 2024 / Notices
clinic characteristics; program reach;
CRC screening practices and outcomes;
clinics’ quality improvement and
monitoring activities; EBI
implementation, and additional factors
that affect EBI implementation over
time. The Quarterly Program Update is
administered in the month following
each program quarter (i.e., October,
January, April, July) and collects
standardized recipient-level information
on aspects of program management,
including: quarterly program
expenditures, current staff vacancies,
program successes and challenges,
current TA needs, and the effect of
COVID–19 on CRCCP implementation at
the recipient level. These data are
collected quarterly to facilitate rapid
reporting of programmatic information
to support CDC program consultants in
providing tailored and meaningful TA.
This information collection enables
CDC to gauge progress in meeting
CRCCP program goals and monitor
implementation activities, evaluate
outcomes, and identify recipients’ TA
needs. In addition, data collected will
inform program improvement and help
identify successful activities that need
to be maintained, replicated, or
expanded. OMB approval is requested
for three years. The total estimated
annualized burden is 760 hours. There
is no cost to respondents other than
their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
CRCCP Recipients .........................................
CRCCP Annual Awardee Survey ..................
CRCCP Clinic-level Information Collection Instrument.
CRCCP Quarterly Program Update ...............
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–09145 Filed 4–26–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Healthcare Infection
Control Practices Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention announces the following
meeting for the Healthcare Infection
Control Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by the
number of audio and web conference
lines (500 audio and web conference
lines are available). Time will be
available for public comment.
Registration is required.
DATES: The meeting will be held on June
6, 2024, from 9 a.m. to 5 p.m., EDT, and
June 7, 2024, 9 a.m. to 12 p.m., EDT.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
VerDate Sep<11>2014
20:54 Apr 26, 2024
Jkt 262001
Please click the link below to join the
June 6 webinar: https://
cdc.zoomgov.com/j/1619798307?
pwd=cmdUT3lFNHFCN
itXZElUdkdnZDRmQT09.
Passcode: fHTc=?7n.
Please click the link below to join the
June 7 Webinar: https://
cdc.zoomgov.com/j/1615598629?
pwd=Ny9pcjhROGR2dGZNeUlmaTQv
QWZxZz09.
Passcode: 8rLxq?*f.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion,
NCEZID, CDC, 1600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027, Telephone: (404) 718–
8039; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Department of Health and Human
Services, regarding (1) the practice of
healthcare infection prevention and
control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related
events in settings where healthcare is
provided; and (3) periodic updating of
CDC guidelines and other policy
statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hr)
35
35
1
24
15/60
50/60
35
4
22/60
Guideline Workgroup; NHSN
workgroup; and Dental Unit Waterlines
Guideline Update. Agenda items are
subject to change.
Public Participation
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below: All
persons interested in making an oral
public comment at the June 6–7, 2024
HICPAC meeting must submit a request
between May 13, 2024, and May 24,
2024, at https://www.cdc.gov/hicpac/
meeting.html no later than 11:59 p.m.,
EDT, May 22, 2024, according to the
instructions provided on the HICPAC
website. If the number of persons
requesting to speak is greater than can
be reasonably accommodated during the
scheduled time, CDC will conduct a
lottery draw to determine the speakers
for the scheduled public comment
session. CDC staff will notify
individuals regarding their request to
speak by email on May 27, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Pages 33352-33353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09145]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-1074]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Colorectal Cancer Control Program (CRCCP)
Monitoring Activities'' to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
December 22, 2023 to obtain comments from the public and affected
agencies. CDC received one comment related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Colorectal Cancer Control Program (CRCCP) Monitoring Activities
(OMB Control No. 0920-1074)--Reinstatement--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a Reinstatement of OMB No. 0920-1074. Colorectal
cancer (CRC) is the second leading cause of death from cancer in the
United States among cancers that affect both men and women. There is
substantial evidence that CRC screening reduces the incidence of and
death from the disease. Screening for CRC can detect disease early when
treatment is more effective, and prevent cancer by finding and removing
precancerous polyps. Of individuals diagnosed with early stage CRC,
more than 90% live five or more years. To reduce CRC morbidity,
mortality, and associated costs, use of CRC screening tests must be
increased among age-eligible adults with the lowest CRC screening
rates.
The purpose of the Colorectal Cancer Control Program (CRCCP) is to
partner with health systems and their individual primary care clinics
to implement evidence-based interventions (EBIs) to increase CRC
screening among defined populations of adults ages 50-75 that have CRC
screening rates lower than the national, regional, or local rate. In
2020, CDC issued the funding opportunity, Public Health and Health
System Partnerships to Increase Colorectal Cancer Screening in Clinical
Settings (DP20-2002), a five-year cooperative agreement to increase CRC
screening among defined populations of adults ages 50-75 that have CRC
screening rates lower than the national, regional, or local rate. DP20-
2002 funds recipients to partner with health systems and their primary
care clinics to implement multiple EBIs, partner with organizations to
support implementation of EBIs in those clinics, and collect high-
quality clinic-level data to monitor EBI implementation and assess
screening rate changes.
CDC proposes information collection using three data collection
tools: the Annual Awardee Survey, Clinic-Level Data Collection
Instrument, and Quarterly Program Update.
The Annual Awardee Survey is administered once per year and
assesses: program management, clinic readiness assessment activities,
data management, technical assistance (TA) needs, partnerships, and the
effect of COVID-19 on CRC implementation. The Clinic-Level Information
Collection Instrument is administered three months following each
program year end and assesses: health system and
[[Page 33353]]
clinic characteristics; program reach; CRC screening practices and
outcomes; clinics' quality improvement and monitoring activities; EBI
implementation, and additional factors that affect EBI implementation
over time. The Quarterly Program Update is administered in the month
following each program quarter (i.e., October, January, April, July)
and collects standardized recipient-level information on aspects of
program management, including: quarterly program expenditures, current
staff vacancies, program successes and challenges, current TA needs,
and the effect of COVID-19 on CRCCP implementation at the recipient
level. These data are collected quarterly to facilitate rapid reporting
of programmatic information to support CDC program consultants in
providing tailored and meaningful TA.
This information collection enables CDC to gauge progress in
meeting CRCCP program goals and monitor implementation activities,
evaluate outcomes, and identify recipients' TA needs. In addition, data
collected will inform program improvement and help identify successful
activities that need to be maintained, replicated, or expanded. OMB
approval is requested for three years. The total estimated annualized
burden is 760 hours. There is no cost to respondents other than their
time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Recipients...................... CRCCP Annual Awardee 35 1 15/60
Survey.
CRCCP Clinic-level 35 24 50/60
Information Collection
Instrument.
CRCCP Quarterly Program 35 4 22/60
Update.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-09145 Filed 4-26-24; 8:45 am]
BILLING CODE 4163-18-P
